Ramya Kartikeyan earned a Ph.D. in virology from Penn State University and worked on malaria and Alzheimer’s research before shifting to bioscience management, earning a master’s degree in that area. After building her expertise in analytics and intelligence at Global Data, InterbrandHealth and Cerner Corporation, Kartikeyan returned to the biopharmaceutical world when she joined Intouch Seven in 2019, rising to VP, strategic planning, with accounts spanning the Chicago and Boston markets. Kartikeyan led many successful campaigns at Intouch, most notably V is for Vyvanse for Takeda’s ADHD product in 2020. In March, Kartikeyan joined Myriad Genetics. Born in Bahrain, Kartikeyan became a U.S. citizen in 2021.